Women Commencing Anastrozole, Letrozole or Tamoxifen for Early Breast Cancer: The Impact of Comorbidity and Demographics on Initial Choice

• Anna Kemp ,

  * E-mail: anna.kemp@uwa.edu.au

  Affiliation Centre for Health Services Research, The University of Western Australia, Perth, Western Australia, Australia

  ⨯
• David B. Preen,

  Affiliation Centre for Health Services Research, The University of Western Australia, Perth, Western Australia, Australia

  ⨯
• Christobel Saunders,

  Affiliation School of Surgery, The University of Western Australia, The University of Western Australia, Perth, Western Australia, Australia

  ⨯
• Frances Boyle,

  Affiliation Patricia Richie Centre for Cancer Care and Research, The Mater Hospital, Sydney, New South Wales, Australia

  ⨯
• Max Bulsara,

  Affiliation Institute of Health Research, University of Notre Dame, Perth, Western Australia, Australia

  ⨯
• C. D’Arcy J. Holman,

  Affiliation Centre for Health Services Research, The University of Western Australia, Perth, Western Australia, Australia

  ⨯
• Eva Malacova,

  Affiliation Centre for Health Services Research, The University of Western Australia, Perth, Western Australia, Australia

  ⨯
• Elizabeth E. Roughead

  Affiliation School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, South Australia, Australia

  ⨯